← Back
$AKRO All transactions

Akero Therapeutics, Inc.

A

$ Value

$0

Shares

9,398

Price

$0

Filed

Jun 5

Insider

Name

Harrison Seth Loring

Title

CIK

0001404955

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

145,699

Footnotes

These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest in full on the earlier of (i) June 3, 2026, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board. | Represents shares held directly by Les Pommes, LLC, a family limited liability company for which the Reporting Person is the manager. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0000950170-25-082310

Form Type

4

Issuer CIK

0001744659

Harrison Seth Loring's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-06-03 STOK A $0

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.